U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C55H58N5O20.Na
Molecular Weight 1132.0603
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of COUMERMYCIN SODIUM

SMILES

[Na+].CO[C@@H]1[C@@H](OC(=O)C2=CC=C(C)N2)[C@@H](O)[C@H](OC3=C(C)C4=C(C=C3)C(O)=C(NC(=O)C5=CNC(C(=O)NC6=C([O-])C7=C(OC6=O)C(C)=C(O[C@@H]8OC(C)(C)[C@H](OC)[C@@H](OC(=O)C9=CC=C(C)N9)[C@H]8O)C=C7)=C5C)C(=O)O4)OC1(C)C

InChI

InChIKey=WTUXHNVTMYDUAM-DHHSFAMCSA-M
InChI=1S/C55H59N5O20.Na/c1-21-12-16-29(57-21)48(67)77-42-38(63)52(79-54(6,7)44(42)71-10)73-31-18-14-26-36(61)34(50(69)75-40(26)24(31)4)59-46(65)28-20-56-33(23(28)3)47(66)60-35-37(62)27-15-19-32(25(5)41(27)76-51(35)70)74-53-39(64)43(45(72-11)55(8,9)80-53)78-49(68)30-17-13-22(2)58-30;/h12-20,38-39,42-45,52-53,56-58,61-64H,1-11H3,(H,59,65)(H,60,66);/q;+1/p-1/t38-,39-,42+,43+,44-,45-,52-,53-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C55H58N5O20
Molecular Weight 1109.0705
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Coumermycin is from the aminocoumarin class of antibiotic compounds which acts by inhibiting DNA gyrase. Coumermycin is effective against gram-positive bacteria, but not gram-negative bacteria. Coumermycin its derivatives have been studied since the 1950's as potential antibiotic. However, it has seen little to no clinical development because of its low water solubility, toxicity profile, and ineffectiveness against gram-negative bacteria.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
1976 Dec
Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
1988 Mar
Combinatorial biosynthesis, metabolic engineering and mutasynthesis for the generation of new aminocoumarin antibiotics.
2008
A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV.
2015 Jan 9
Patents

Sample Use Guides

Lethal septicemia was induced in mice by intraperitoneal administration of Methicillin-Resistant Staphylococcus. The infection was successfully treated in 50% of the animals (ED50) following a dose of 0.9 micro-g/g body weight. This was significantly better than ofloxacin and vancomycin.
Route of Administration: Other
In Vitro Use Guide
The antibiotic ability of coumermycin was evaluated against 232 bacterial strains. Minimal inhibitory concentrations (MIC) were determined in trypticase soy broth using twofold serial dilutions. The last tube in a series to show no visible growth after 18 hours at 37 deg-C was considered the MIC. Strain specific MIC's were reported between 0.002 micro-g/L and 100 micro-g/L.
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:13:11 GMT 2023
Edited
by admin
on Sat Dec 16 05:13:11 GMT 2023
Record UNII
1VHT58TJ83
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
COUMERMYCIN SODIUM
USAN  
USAN  
Official Name English
COUMERMYCIN SODIUM [USAN]
Common Name English
RO-5-4645/010
Code English
SODIUM COUMERMYCIN A1
Common Name English
RO 5-4645/010
Code English
1H-PYRROLE-2,4-DICARBOXAMIDE, N2,N4-BIS(7-((6-DEOXY-5-C-METHYL-4-O-METHYL-3-O-((5-METHYL-1H-PYRROL-2-YL)CARBONYL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-3-METHYL-, SODIUM SALT (1:1)
Common Name English
Code System Code Type Description
NCI_THESAURUS
C166516
Created by admin on Sat Dec 16 05:13:11 GMT 2023 , Edited by admin on Sat Dec 16 05:13:11 GMT 2023
PRIMARY
USAN
W-15
Created by admin on Sat Dec 16 05:13:11 GMT 2023 , Edited by admin on Sat Dec 16 05:13:11 GMT 2023
PRIMARY
CAS
4575-42-2
Created by admin on Sat Dec 16 05:13:11 GMT 2023 , Edited by admin on Sat Dec 16 05:13:11 GMT 2023
PRIMARY
FDA UNII
1VHT58TJ83
Created by admin on Sat Dec 16 05:13:11 GMT 2023 , Edited by admin on Sat Dec 16 05:13:11 GMT 2023
PRIMARY
PUBCHEM
76968266
Created by admin on Sat Dec 16 05:13:11 GMT 2023 , Edited by admin on Sat Dec 16 05:13:11 GMT 2023
PRIMARY
ChEMBL
CHEMBL1908352
Created by admin on Sat Dec 16 05:13:11 GMT 2023 , Edited by admin on Sat Dec 16 05:13:11 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY